We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Gastroenterology

Journal Scan / Research · October 15, 2021

Chronic Use of Ranitidine Not Found to Be Associated With GI Cancer

Alimentary Pharmacology & Therapeutics

 

Additional Info

Disclosure statements are available on the authors' profiles:

Alimentary Pharmacology & Therapeutics
No association between chronic use of ranitidine, compared with omeprazole or famotidine, and gastrointestinal malignancies
Aliment. Pharmacol. Ther. 2021 Sep 01;54(5)606-615, YD Kim, J Wang, F Shibli, KE Poels, SJ Ganocy, R Fass

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading